<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00982501</url>
  </required_header>
  <id_info>
    <org_study_id>501004.01.103</org_study_id>
    <nct_id>NCT00982501</nct_id>
  </id_info>
  <brief_title>WS®1442 in Slightly Overweight Subjects</brief_title>
  <official_title>Investigation of Safety of WS®1442 in Slightly Overweight Subjects With Pilot Assessment of Pharmacodynamic Effects of WS®1442 on Endothelial Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Willmar Schwabe GmbH &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dr. Willmar Schwabe GmbH &amp; Co. KG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test:

        1. Safety of 900 mg or 1800 mg of WS® 1442 per day in overweight subjects (BMI 25 to 29,9
           kg/m²)

        2. Pharmacodynamic effect of WS® 1442 on endothelial function versus nordic walking
           training in overweight subjects
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      60 overweight subjects with a BMI of 25 to 29,9 kg/m2 are to be included. The safety of 900
      mg/1800 mg per day WS® 1442 is determined by adverse events, laboratory parameters, vital
      signs as well as by a treadmill test at the beginning and the end of the study. Endothelial
      function measured before and after two different training modalities is compared to that
      measured before and after intake of two different doses of WS® 1442.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adverse events</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Lab parameters</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Vital signs</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Treadmill test including lactate measurement</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Endothelial function</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Overweight</condition>
  <arm_group>
    <arm_group_label>WS® 1442 900 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>WS® 1442 1800 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Nordic walking training 2x30 min</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Nordic walking training 4x45 min</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>WS® 1442 900 mg/d</intervention_name>
    <arm_group_label>WS® 1442 900 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>WS® 1442 1800 mg/d</intervention_name>
    <arm_group_label>WS® 1442 1800 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Nordic walking training 2 x 30 min/week</intervention_name>
    <arm_group_label>Nordic walking training 2x30 min</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Nordic walking training 4x45 min/week</intervention_name>
    <arm_group_label>Nordic walking training 4x45 min</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  written informed consent

          -  male and female subjects aged 45-75 years

          -  untrained

          -  BMI between 25 and 29,9 kg/m²

          -  resting blood pressure in sitting position ≤ 140/90 mmHg

          -  inconspicuous ergometry

        Exclusion Criteria:

          -  pregnancy or breastfeeding

          -  any other current medication

          -  intake of other hawthorn preparation or dietary supplements with possible influence on
             the interpretation of study results

          -  any known diseases

          -  alcohol or drug abuse/addiction

          -  nicotine abuse

          -  any known hypersensitivity to any of the ingredients of the investigated drug

          -  inability or inadequate ability to write or speak German

          -  not-postmenopausal women: positive pregnancy test or unsafe contraception

          -  any urinary test finding requiring diagnostic assessment or treatment

          -  deformation of the 2nd to 5th finger of both hands preventing an adequate measurement
             of endothelial function
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Josef Niebauer, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Institute of Sports Medicine, Prevention and Rehabilitation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Institute of Sports Medicine, Prevention and Rehabilitation, Paracelsus Medical University Salzburg</name>
      <address>
        <city>Salzburg</city>
        <zip>5020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 22, 2009</study_first_submitted>
  <study_first_submitted_qc>September 22, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2009</study_first_posted>
  <last_update_submitted>May 13, 2014</last_update_submitted>
  <last_update_submitted_qc>May 13, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 14, 2014</last_update_posted>
  <responsible_party>
    <name_title>Professor Josef Niebauer, M.D., Ph.D.</name_title>
    <organization>Universitaetsinstitut fuer praeventive und rehabilitative Sportmedizin der Paracelsus Medizinischen Privatuniversitaet, Institut fuer Sportmedizin des Landes Salzburg, Lindhofstr. 20, 5020 Salzburg, Austria</organization>
  </responsible_party>
  <keyword>(BMI 25-29,9 kg/m2)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

